Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Aurobindo Pharma, Dr Reddy's Laboratories; sell HPCL: Rajat Bose

      Rajat Bose of rajatkbose.com advises selling Hindustan Petroleum Corporation and suggests buying Aurobindo Pharma, Dr Reddy's Laboratories.

    • Buy, Sell, Hold: What stocks and sectors are on analysts' radar today?

      GAIL, Reliance and Reliance, among others, are being tracked by investors' radar.

    • Buy Dr Reddy's Laboratories, Engineers India: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com advises buying Dr Reddy's Laboratories and Engineers India.

    • Sell Vedanta; buy Dr Reddy’s Lab, Dewan Housing Finance: Yogesh Mehta

      Yogesh Mehta of Motilal Oswal is of the view that one may buy Dr Reddy’s Laboratories and Dewan Housing Finance.

    • Buy Dr Reddy's Laboratories on dips: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com advises buying Dr Reddy's Laboratories.

    • Sell Canara Bank, Ceat: Mitessh Thakkar

      According to Mitessh Thakkar of mitesshthakkar.com, one may sell Canara Bank and Ceat.

    • Buy Mahindra & Mahindra, DLF, GIC Housing Finance: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Mahindra and Mahindra, DLF and GIC Housing Finance.

    • Buy, Sell, Hold: 3 stocks and 3 sectors are being tracked by analysts today

      Tata Motors, Axis Bank, pharma and telecom, among others are on the radar of investors on Monday.

    • Buy Tata Motors DVR, SREI Infrastructure, Dr Reddy's Labs: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Tata Motors DVR, SREI Infrastructure Finance and Dr Reddy's Laboratories.

    • Here are some fundamental trading ideas from SP Tulsian

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.

    • Positive on pharma; buy Dr Reddys, Cipla, Aurobindo: Rahul Arora

      In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities, shared his views on various stocks and sectors.

    • Stay away from pharma space, exit Sun Pharma: Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may stay away from pharma space.

    • Here are SP Tulsian's top trading picks

      In an interview to CNBC-TV18's Surabhi Upadhyay and Reema Tendulkar, SP Tulsian shared his outlook and readings on the fundamentals of the market and specific stocks.

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Surabhi Upadhyay and Nigel D'souza, SP Tulsian shared his readings and outlook on the fundamentals of the market and specific stocks.

    • Why did pharmaceutical stocks take a hit today?

      Individual news flow along with negative outlook for the sector by Credit Suisse hit the sector. Frontline stocks tank, pulling down the markets further.

    • Here are SP Tulsian's top trading picks

    • Buy NMDC, Dr Reddy's Laboratories: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests buying NMDC and Dr Reddy's Laboratories.

    • Buy, Sell, Hold: Here are 6 stocks that analysts are tracking today

      Titan, Yes Bank, and Idea Cellular, among others, are on the radar of analysts on Monday.

    • Buy NBCC, Muthoot Finance, Shree Cements, BPCL; sell Dr Reddy's Labs: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying NBCC, Muthoot Finance, Shree Cements and Bharat Petroleum Corporation and advises selling Dr Reddy's Laboratories.

    • Buy, sell, hold: 12 stocks & 2 sectors on analysts' radar as market at record high

      ITC, UPL, Dr. Reddy's, among others are being watched by analysts, while steel and oil and gas too remain on their radar.

    • Here are fundamental trading ideas from SP Tulsian

      In an interview to CNBC-TV18’s Latha Venkatesh, Anuj Singhal, and Sonia Shenoy, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.

    • Buy, Sell, Hold: 9 stocks, 1 sector on analysts' radar as April series begins

      From Cipla to Yes Bank and Power Grid, a look at what brokerages are talking about these stocks.

    • Buy YES Bank, Aditya Birla Nuvo, Bata India; sell M&M, Apollo Hospitals: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy YES Bank, Aditya Birla Nuvo and Bata India and sell M&M and Apollo Hospitals.

    • Sell Dr Reddy’s Laboratories, Axis Bank, Bharat Forge, TVS Motor; buy ICICI Bank: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Dr Reddy’s Laboratories, Axis Bank, Bharat Forge and TVS Motor and advises buying ICICI Bank.

    • Buy, Sell, Hold: Which stocks are analysts tracking today?

      Morgan Stanley has initiated coverage on the stock with an outperform rating and forecasts 30 percent free cash flow CAGR in FY17-19.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347